Wacker Chemie (WCH) Investor presentation summary

Financial performance and business overview

• Achieved €6.4bn in sales and €824m EBITDA in 2023, with a 13% EBITDA margin and 16,378 employees across 27 production sites and four business segments.

• Q2 2024 saw sales of €1,468m, a 16% YoY decrease, and EBITDA of €160m, down 37% YoY, with a 10.9% EBITDA margin.

• Polysilicon and Silicones remain strong contributors, with Polysilicon holding a #1 position in semi and high-end solar markets.

• Polymers and Biosolutions segments focus on innovation, sustainability, and advanced medicine, with Biosolutions showing rapid growth in biotechnology.

Strategic targets and growth initiatives

• Aims for sales above €10bn and EBITDA margin over 20% by 2030, with volume/mix CAGR 1.5–2x historic and ROCE twice the cost of capital.

• Growth CapEx prioritized for chemical capacity expansion and diversified downstream projects, with continued ~50% net income payout as dividends.

• Strategic focus on specialties in Silicones, tandem products in Polymers, biologics in Biosolutions, and semi in Polysilicon.

Sustainability and ESG progress

• Targets 50% reduction in absolute GHG emissions, 15% reduction in energy and water use, and 100% of products and key suppliers meeting sustainability criteria by 2030.

• Progress includes 94% of products meeting sustainability criteria and 21% of management positions held by women as of 2023.

• Committed to net zero by 2045 and alignment with the Paris Agreement’s 1.5°C target.